Publication | Closed Access

Multiple targeted doxorubicin-lonidamine liposomes modified with p-hydroxybenzoic acid and triphenylphosphonium to synergistically treat glioma

Neuro-oncologyMedicinal ChemistryP-hydroxybenzoic AcidDrug TargetingGliomaPolymer-drug ConjugateMedicineTumor TargetingAnti-cancer AgentHigh-grade GliomasDoxorubicin-lonidamine LiposomesCancer TreatmentPharmacologyRadiation OncologyTumor BiologyDrug Discovery